Results
2302
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2302 companies
Arcturus Therapeutics Holdings
Market Cap: US$330.9m
Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.
ARCT
US$12.03
7D
-5.3%
1Y
-68.7%
iTeos Therapeutics
Market Cap: US$327.6m
A clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.
ITOS
US$8.53
7D
2.2%
1Y
-50.1%
Nano-X Imaging
Market Cap: US$327.4m
Develops a commercial-grade tomographic imaging device with a digital X-ray source.
NNOX
US$5.18
7D
-5.6%
1Y
-39.0%
Alpha Teknova
Market Cap: US$319.0m
Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
TKNO
US$5.87
7D
-12.6%
1Y
230.7%
Outset Medical
Market Cap: US$318.1m
A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
OM
US$18.79
7D
-3.7%
1Y
-68.5%
Cidara Therapeutics
Market Cap: US$314.9m
Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.
CDTX
US$24.00
7D
-10.8%
1Y
103.9%
Varex Imaging
Market Cap: US$312.2m
Designs, manufactures, and sells X-ray imaging components.
VREX
US$7.83
7D
-3.8%
1Y
-47.8%
Abeona Therapeutics
Market Cap: US$311.6m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$6.12
7D
-4.7%
1Y
49.3%
National Research
Market Cap: US$309.7m
Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.
NRC
US$13.64
7D
-1.2%
1Y
-54.7%
Aurora Cannabis
Market Cap: CA$426.4m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$7.57
7D
2.0%
1Y
-12.0%
Cytek Biosciences
Market Cap: US$306.5m
A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
CTKB
US$2.57
7D
-3.4%
1Y
-56.7%
EBR Systems
Market Cap: AU$474.2m
Develops implantable systems for wireless tissue stimulation.
EBR
AU$1.11
7D
-9.1%
1Y
4.7%
Cresco Labs
Market Cap: CA$422.0m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.
CL
CA$0.92
7D
-8.0%
1Y
-63.1%
Cryoport
Market Cap: US$302.8m
Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.
CYRX
US$6.03
7D
-10.5%
1Y
-45.8%
XOMA Royalty
Market Cap: US$297.4m
Operates as a biotech royalty aggregator in the United States and the Asia Pacific.
XOMA
US$24.92
7D
-6.3%
1Y
-2.3%
Canopy Growth
Market Cap: CA$401.8m
Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.
WEED
CA$2.35
7D
-3.3%
1Y
-79.7%
Imricor Medical Systems
Market Cap: AU$449.3m
A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.
IMR
AU$1.66
7D
3.1%
1Y
232.0%
American Oncology Network
Market Cap: US$289.0m
Through its subsidiaries, provides oncology management services in the United States.
AONC
US$6.36
7D
-8.5%
1Y
169.5%
Compass Therapeutics
Market Cap: US$289.0m
A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.
CMPX
US$2.11
7D
0.5%
1Y
37.9%
NervGen Pharma
Market Cap: CA$390.4m
A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.
NGEN
CA$5.58
7D
-7.0%
1Y
179.0%
Heron Therapeutics
Market Cap: US$282.2m
A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.
HRTX
US$1.89
7D
-1.6%
1Y
-44.6%
Phathom Pharmaceuticals
Market Cap: US$280.0m
A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.
PHAT
US$4.12
7D
-5.9%
1Y
-60.0%
Immutep
Market Cap: AU$430.8m
A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.29
7D
-1.7%
1Y
-33.0%
Pacific Biosciences of California
Market Cap: US$276.6m
Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.
PACB
US$0.91
7D
-10.8%
1Y
-51.5%
Gossamer Bio
Market Cap: US$272.8m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.
GOSS
US$1.12
7D
-5.1%
1Y
88.4%
Tvardi Therapeutics
Market Cap: US$272.3m
Operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases.
TVRD
US$33.39
7D
20.4%
1Y
n/a
Candel Therapeutics
Market Cap: US$272.1m
A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.
CADL
US$5.60
7D
-5.2%
1Y
-34.5%
Ocugen
Market Cap: US$271.8m
A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.
OCGN
US$0.96
7D
18.3%
1Y
-44.0%
Sanara MedTech
Market Cap: US$270.1m
A medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.
SMTI
US$30.78
7D
-0.8%
1Y
0.8%
Oncology Institute
Market Cap: US$269.5m
An oncology company, provides various medical oncology services in the United States.
TOI
US$3.01
7D
8.3%
1Y
528.4%
Corvus Pharmaceuticals
Market Cap: US$269.1m
A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.
CRVS
US$3.67
7D
-0.3%
1Y
81.7%
Alumis
Market Cap: US$265.2m
A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.
ALMS
US$4.45
7D
-8.8%
1Y
n/a
Entrada Therapeutics
Market Cap: US$264.4m
A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.
TRDA
US$7.70
7D
-6.6%
1Y
-52.3%
Terns Pharmaceuticals
Market Cap: US$263.8m
A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.
TERN
US$3.01
7D
-4.4%
1Y
-52.4%
Oceania Healthcare
Market Cap: NZ$441.8m
Owns and operates retirement villages and care centres in New Zealand.
OCA
NZ$0.61
7D
-4.7%
1Y
8.9%
Neuronetics
Market Cap: US$262.6m
Engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
STIM
US$3.97
7D
-7.5%
1Y
90.9%